Spreadsheets are still useful, but if you do a lot of work with numbers, you'll realize that they have limitations.

The professionalisation of women’s cricket in South Africa has produced many stars that continue to shine through the ...

Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...

Daniel Jassy, CFA, is an Investopedia Academy instructor and the founder of SPYderCRusher Research. He contributes to Excel and Algorithmic Trading. Amy is an ACA and the CEO and founder of OnPoint ...

Pierre Cardin, Angola, Marketing Strategy, Cosmetic Industry, Localization, Consumer Behavior, 7Ps, Digital Marketing Share and Cite: Nolatu, F.A.J. (2025) Research on Optimization of Marketing ...

As of the end of June 2025, the most recent reporting period, 117.3 million people had been forced to flee their homes globally due to persecution, conflict, violence, human rights violations or ...

About four-in-five Latinos in the U.S. say Trump’s policies harm Hispanics, a higher share than during his first term. Fresh data delivered Saturday mornings Thank you for subscribing! Most Americans ...

Objective Handgrip strength (HGS) is a simple, non-invasive measure associated with disability, frailty and disease activity ...

Titans captain Gandhi Jafta merges elite cricket performance with academic ambition, earning top honours while pursuing her ...

Tsono Andzelet, S.A. (2025) Determinants of Consumer Choice in Retail Supermarkets: A Case of Brazzaville, Republic of the Congo. Open Access Library Journal, 12, 1-17. doi: 10.4236/oalib.1114505 .

Background: Primary care physicians, who manage the care of most children with asthma, often do not optimally assess disease control, prescribe asthma controller medications, or provide family asthma ...

Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...